⚡ LATEST
FDA Panel Eases Peptide Rules After Online Surge

FDA Panel Eases Peptide Rules After Online Surge

The FDA panel on peptide rules voted to loosen limits on compounds like BPC-157 and KPV, a move that could open the door to prescriptions.

An FDA panel on peptide rules voted to loosen restrictions on controversial compounds that have surged online, including BPC-157, TB-500 and KPV. The decision marks a major step toward allowing specialized pharmacies to make the drugs for prescription use, even though the products have not been well studied in humans.

The advisory committee voted narrowly in favor of letting compound pharmacies produce the peptides, which are small proteins the body normally makes and has long used in medical treatment, including for diabetes. The agency is not required to follow the panel’s advice, but it often does. The vote comes as Health Secretary Robert F. Kennedy has publicly called himself a big fan of the drugs and has said he wants to ease the restrictions put in place under the Biden administration.

Peptides have become a fixture in the online wellness world, especially after GLP-1 weight-loss drugs became widely known. Influencers have promoted them in stacks for unproven uses, saying they can help people look younger, speed healing and improve skin. The trend has also spread among teens on TikTok, particularly boys, where some users link the drugs to muscle building and body enhancement with labels like biohacking and looksmaxxing.

Health experts have warned against the craze, pointing to the lack of human clinical trials and the unknown long-term effects. BPC-157, one of the most talked-about peptides, is made from stomach protein and is marketed online for gut health, tissue repair and inflammation. It has been studied in animals for possible muscle healing. The US Anti-Doping Agency says no one knows whether there is a safe dose or a safe way to use it for specific medical conditions, and the World Anti-Doping Agency bans it in sport.

KPV is also being promoted online for gut health, tissue repair, skin issues such as acne and immune system regulation. Both BPC-157 and KPV sit in a gray zone: they are not illegal to buy or own and are widely available online, but they are not approved for human use and are not covered by the manufacturing quality controls that apply to approved drugs. Panel member Elizabeth Rebello, a pharmacist and anaesthesiologist, told the committee she voted no on BPC-157 because of safety concerns and a lack of efficacy data, while other supporters reportedly cited medical freedom and the greater good. The panel will keep debating the issue on Friday, and the FDA still has the final say. For American consumers, the fight is about whether a fast-growing online trend should move closer to mainstream medicine without stronger proof it is safe or works.

Frequently asked questions

What did the FDA panel vote to do with these peptides?
The panel voted narrowly to let compound pharmacies produce peptides such as BPC-157, TB-500 and KPV for prescription use. The FDA can still choose not to follow that advice.
Why are BPC-157 and KPV controversial?
They are heavily promoted online for uses like gut health, tissue repair, skin issues and immune regulation, but they have not been well studied in humans. Experts also warn that their long-term effects and safe dosing are unknown.
Are these peptides illegal to buy or own?
No. The article says BPC-157 and KPV are not illegal to buy or own and are widely available online, but they are not approved for human use.
Who is pushing for fewer restrictions on peptides?
Health Secretary Robert F. Kennedy has publicly said he is a big fan of the drugs and wants to ease restrictions put in place under the Biden administration.

More from US News

View all →
📨

Never Miss a Story

Get the headlines that matter delivered straight to your inbox.